Targeting IL-8 in colorectal cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.5, 2012-05, pp. : 491-497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting IL-8 signalling to inhibit breast cancer stem cell activity

By Singh Jagdeep K Simões Bruno M Clarke Robert B Bundred Nigel J

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1235-1241

Informa Healthcare

Access to resources Recommend Favorite

Targeting NF-κB for colorectal cancer

By Sakamoto Kei Maeda Shin

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 593-601

Informa Healthcare

Access to resources Recommend Favorite

Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer

By Lu Hailing Goodell Vivian Disis Mary L

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 235-244

Informa Healthcare

Access to resources Recommend Favorite

Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting

By Rolfo Christian

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 869-871

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B. Fourie Jeanne

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite